Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress

Galectin 1 Proangiogenic and Promigratory Effects in the Hs683 Oligodendroglioma Model Are Partly Mediated through the Control of BEX2 Expression

(2015) Marie Le Mercier et al.   NEOPLASIA

Galectin inhibitory disaccharides promote tumour immunity in a breast cancer model

(2010) Kimberley A. Stannard et al.   CANCER LETTERS

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

(2010) V. L. Thijssen et al.   CANCER RESEARCH

Antiangiogenic Agents Can Increase Lymphocyte Infiltration into Tumor and Enhance the Effectiveness of Adoptive Immunotherapy of Cancer

(2010) R. K. Shrimali et al.   CANCER RESEARCH

Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells

(2010) Xu-Yun Zhao et al.   CARCINOGENESIS

Mitochondria and Hypoxic Signaling

(2009) Robert O. Poyton et al.   Annals of the New York Academy of Sciences

Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses

(2009) Marie Le Mercier et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Characterisation of Oxidized Recombinant Human Galectin-1

(2009) Stacy A. Scott et al.   PROTEIN AND PEPTIDE LETTERS

The Galectin Profile of the Endothelium

(2008) Victor L. Thijssen et al.   AMERICAN JOURNAL OF PATHOLOGY

Anti-angiogenesis: making the tumor vulnerable to the immune system

(2008) Arjan W. Griffioen   CANCER IMMUNOLOGY IMMUNOTHERAPY

Galectin-Inhibitory Thiodigalactoside Ester Derivatives Have Antimigratory Effects in Cultured Lung and Prostate Cancer Cells

(2008) Tamara Delaine et al.   JOURNAL OF MEDICINAL CHEMISTRY

Vascular normalization in Rgs5-deficient tumours promotes immune destruction

(2008) Juliana Hamzah et al.   NATURE

Serum Galectin-1 and Galectin-3 Levels in Benign and Malignant Nodular Thyroid Disease

(2008) Sven Saussez et al.   THYROID

Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking

(2007) Lucy V. Norling et al.   FASEB JOURNAL

The determination of the levels of circulating galectin-1 and -3 in HNSCC patients could be used to monitor tumor progression and/or responses to therapy

(2007) Sven Saussez et al.   ORAL ONCOLOGY

Overexpression of galectin-1 at the tumor invasion front is associated with poor prognosis in early-stage oral squamous cell carcinoma

(2007) Wei-Fan Chiang et al.   ORAL ONCOLOGY